STRATEC SE (SBS) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

30.89 k

Shareholding (Dec 2023)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

EUR 278 Million ()

P/E

21.00

Industry P/E

Dividend Yield

2.63%

Debt Equity

0.46

Return on Equity

7.18%

Price to Book

1.16

Revenue and Profits:

Net Sales:

81 Million

(Quarterly Results - Dec 2024)

Net Profit:

12 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-10.74%

6 Months

-14.9%

1 Year

-23.58%

2 Years

-42.23%

3 Years

-73.58%

4 Years

-81.78%

5 Years

-80.47%

STRATEC SE for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

3.40%

EBIT Growth (5y)

6.44%

EBIT to Interest (avg)

20.46

Debt to EBITDA (avg)

1.24

Net Debt to Equity (avg)

0.29

Sales to Capital Employed (avg)

0.71

Tax Ratio

27.20%

Dividend Payout Ratio

45.52%

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

13.37%

ROE (avg)

12.20%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.40

EV to EBIT

16.57

EV to EBITDA

9.58

EV to Capital Employed

1.27

EV to Sales

1.72

PEG Ratio

0.92

Dividend Yield

2.20%

ROCE (Latest)

7.69%

ROE (Latest)

6.77%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2023

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 42.13% vs -16.13% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 2,220.00% vs -85.71% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "81.30",
          "val2": "57.20",
          "chgp": "42.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "21.60",
          "val2": "8.30",
          "chgp": "160.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "1.40",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "11.60",
          "val2": "0.50",
          "chgp": "2,220.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "202.80%",
          "val2": "60.50%",
          "chgp": "14.23%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -4.73% vs -1.53% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 3.90% vs -47.26% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "257.60",
          "val2": "270.40",
          "chgp": "-4.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "44.90",
          "val2": "45.80",
          "chgp": "-1.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5.80",
          "val2": "3.90",
          "chgp": "48.72%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.60",
          "val2": "0.50",
          "chgp": "-220.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "16.00",
          "val2": "15.40",
          "chgp": "3.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "100.10%",
          "val2": "104.00%",
          "chgp": "-0.39%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ

Dec'24

Sep'24

Change(%)

Net Sales

81.30

57.20

42.13%

Operating Profit (PBDIT) excl Other Income

21.60

8.30

160.24%

Interest

1.40

Exceptional Items

0.00

Consolidate Net Profit

11.60

0.50

2,220.00%

Operating Profit Margin (Excl OI)

202.80%

60.50%

14.23%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2024 is 42.13% vs -16.13% in Sep 2024

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 2,220.00% vs -85.71% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

257.60

270.40

-4.73%

Operating Profit (PBDIT) excl Other Income

44.90

45.80

-1.97%

Interest

5.80

3.90

48.72%

Exceptional Items

-0.60

0.50

-220.00%

Consolidate Net Profit

16.00

15.40

3.90%

Operating Profit Margin (Excl OI)

100.10%

104.00%

-0.39%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -4.73% vs -1.53% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 3.90% vs -47.26% in Dec 2023

All Annual Results

Company CV

About STRATEC SE

STRATEC SE

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available